Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul
Kronox Lab Sciences Ltd 路 Change in Management 路 29 Sept 2026, 11:49 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Leadership Overhaul Promoters of Kronox Lab Sciences completed the sale of a 64.26% stake (2,38,44,000 shares) to Indo Borax & Chemicals on 29th Sep'26, reducing their collective holding to 9.95% and ceasing to be promoters. Consequently, the board underwent a full overhaul: Suresh Kalra was appointed MD & CEO, Sunil Malhotra as Whole-time Director, and Shashikant Bharuka as CFO, alongside three new independent directors. Erstwhile promoter-directors resigned and entered 36-month transition consultancy agreements at an aggregate fee of INR 2.10 crore each.
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... 路 11 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2026 for Indo Borax .... 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd 路 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd 路 06 Nov 2026
- IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation .... 路 05 Nov 2026
- Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026 路 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 路 05 Nov 2026
